Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Extension Study to Evaluate the Efficacy and Safety of BMN 111 in Children With Achondroplasia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03424018
Recruitment Status : Enrolling by invitation
First Posted : February 6, 2018
Last Update Posted : May 30, 2019
Sponsor:
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : October 2024
Estimated Study Completion Date : December 2024